Skip to main content
Log in

Healthcare costs higher in US patients with RA not achieving remission

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2019 US dollars

Reference

  • Bergman M, et al. Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study. Advances in Therapy : 9 Apr 2021. Available from: URL: http://doi.org/10.1007/s12325-021-01730-w

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Healthcare costs higher in US patients with RA not achieving remission. PharmacoEcon Outcomes News 876, 16 (2021). https://doi.org/10.1007/s40274-021-7630-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7630-2

Navigation